Ercros, S.A. (BME:ECR)

Market Cap	297.17M
Revenue (ttm)	656.52M
Net Income (ttm)	14.10M
Shares Out	91.44M
EPS (ttm)	n/a
PE Ratio	21.07
Forward PE	n/a
Dividend	0.10 (2.92%)
Ex-Dividend Date	Jul 8, 2024

Volume	34,600
Average Volume	54,000
Open	3.320
Previous Close	3.285
Day's Range	3.235 - 3.335
52-Week Range	2.275 - 3.980
Beta	0.70
RSI	30.14
Earnings Date	Feb 21, 2025

About Ercros

Ercros, S.A. manufactures and sells basic chemicals, intermediate chemicals, and pharmaceuticals in Spain. It operates through three segments: Chlorine Derivatives, Intermediate Chemicals, and Pharmacy. The Chlorine Derivatives segment produces ammonia, bioplastics, caustic potash and soda, chlorine, chloroisocyanurates, dicalcium phosphate, dichloroethane, hydrochloric acid, hydrogen peroxide, potassium carbonate, PVC compounds, sodium chlorate and chlorite, sodium hypochlorite, and vinyl chloride monomers and polychloride. This segment’s prod...

• Industry: Chemicals
• Sector: Materials
• Founded: 1817
• Employees: 1,253
• Stock Exchange: Madrid Stock Exchange
• Ticker Symbol: ECR

Financial Performance

In 2023, Ercros's revenue was 726.29 million, a decrease of -29.19% compared to the previous year's 1.03 billion. Earnings were 27.59 million, a decrease of -56.21%.